Buying time: a rationale for examining the use of circadian rhythm and sleep interventions to delay progression of mild cognitive impairment to Alzheimer's disease.

PubWeight™: 0.84‹?›

🔗 View Article (PMC 4259166)

Published in Front Aging Neurosci on December 08, 2014

Authors

Glenn J Landry1, Teresa Liu-Ambrose2

Author Affiliations

1: Aging, Mobility, and Cognitive Neuroscience Laboratory, Department of Physical Therapy, Faculty of Medicine, University of British Columbia Vancouver, BC, Canada ; Djavad Mowafaghian Centre for Brain Health, University of British Columbia Vancouver, BC, Canada.
2: Aging, Mobility, and Cognitive Neuroscience Laboratory, Department of Physical Therapy, Faculty of Medicine, University of British Columbia Vancouver, BC, Canada ; Djavad Mowafaghian Centre for Brain Health, University of British Columbia Vancouver, BC, Canada ; Brain Research Centre, University of British Columbia Vancouver, BC, Canada.

Articles cited by this

(truncated to the top 100)

A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep (1991) 44.17

Mild cognitive impairment: clinical characterization and outcome. Arch Neurol (1999) 33.06

The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement (2011) 21.80

Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun (1984) 20.07

Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet (2009) 15.15

Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci U S A (1993) 15.04

Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86

Inflammation and Alzheimer's disease. Neurobiol Aging (2000) 12.56

Fitness effects on the cognitive function of older adults: a meta-analytic study. Psychol Sci (2003) 11.59

Forecasting the global burden of Alzheimer's disease. Alzheimers Dement (2007) 10.01

The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep (2003) 9.71

Sleep drives metabolite clearance from the adult brain. Science (2013) 9.65

Effect of physical activity on cognitive function in older adults at risk for Alzheimer disease: a randomized trial. JAMA (2008) 8.84

Cognitive reserve. Neuropsychologia (2009) 8.41

Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective. Cell (2005) 8.40

Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun (1984) 8.14

The global prevalence of dementia: a systematic review and metaanalysis. Alzheimers Dement (2013) 7.69

Local sleep and learning. Nature (2004) 7.67

Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet (1994) 7.07

Cardiovascular fitness, cortical plasticity, and aging. Proc Natl Acad Sci U S A (2004) 6.53

Sleep complaints among elderly persons: an epidemiologic study of three communities. Sleep (1995) 6.42

Neuropathologic features of amnestic mild cognitive impairment. Arch Neurol (2006) 6.20

The metabolic consequences of sleep deprivation. Sleep Med Rev (2007) 6.07

Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep (1986) 6.04

Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med (2005) 5.83

Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev (2006) 5.61

The role of apolipoprotein E in Alzheimer's disease. Neuron (2009) 5.55

Sleep-dependent memory consolidation. Nature (2005) 5.42

Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J (2011) 5.30

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. Diabetes (2002) 4.97

Glucose levels and risk of dementia. N Engl J Med (2013) 4.95

Effects of aerobic exercise on mild cognitive impairment: a controlled trial. Arch Neurol (2010) 4.78

2013 Alzheimer's disease facts and figures. Alzheimers Dement (2013) 4.75

Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study. Lancet Neurol (2006) 4.54

Apolipoprotein E polymorphism and Alzheimer's disease. Lancet (1993) 4.47

Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease. Neurobiol Aging (2009) 4.36

Tolerance of debility in elderly dependants by supporters at home: its significance for hospital practice. Br Med J (1975) 4.20

Human apoE isoforms differentially regulate brain amyloid-β peptide clearance. Sci Transl Med (2011) 4.07

Contribution of the circadian pacemaker and the sleep homeostat to sleep propensity, sleep structure, electroencephalographic slow waves, and sleep spindle activity in humans. J Neurosci (1995) 4.02

Stages of the pathologic process in Alzheimer disease: age categories from 1 to 100 years. J Neuropathol Exp Neurol (2011) 3.69

Caregivers of the frail elderly: a national profile. Gerontologist (1987) 3.67

Timing of human sleep: recovery process gated by a circadian pacemaker. Am J Physiol (1984) 3.59

The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability, and covariability of cholesterol, betalipoprotein, and triglycerides in a sample of unrelated individuals. Am J Med Genet (1987) 3.57

Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med (2006) 3.56

Resistance training and executive functions: a 12-month randomized controlled trial. Arch Intern Med (2010) 3.54

Sleep-dependent learning and memory consolidation. Neuron (2004) 3.42

Can training in a real-time strategy video game attenuate cognitive decline in older adults? Psychol Aging (2008) 3.32

Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial. Diabetes Care (2009) 3.30

A phase response curve to single bright light pulses in human subjects. J Physiol (2003) 3.29

Alzheimer neuropathologic alterations in aged cognitively normal subjects. J Neuropathol Exp Neurol (1999) 3.20

Sleep in normal aging and dementia. Sleep (1993) 3.18

The incidence of dementia: a meta-analysis. Neurology (1998) 3.06

Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology (2011) 2.91

Vascular risk factors for Alzheimer's disease: an epidemiologic perspective. Neurobiol Aging (2000) 2.77

Epidemiology of the human circadian clock. Sleep Med Rev (2007) 2.71

Bright light induction of strong (type 0) resetting of the human circadian pacemaker. Science (1989) 2.66

The "other" circadian system: food as a Zeitgeber. J Biol Rhythms (2002) 2.57

Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease. Ann Intern Med (2004) 2.56

Physiology of circadian entrainment. Physiol Rev (2010) 2.51

Circadian food-anticipatory activity: formal models and physiological mechanisms. Neurosci Biobehav Rev (1994) 2.50

Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann Neurol (2011) 2.46

Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a 'thrifty' allele? Ann Hum Genet (1999) 2.40

The relative frequency of "dementia of unknown etiology" increases with age and is nearly 50% in nonagenarians. Arch Neurol (2000) 2.35

Actions of melatonin in the reduction of oxidative stress. A review. J Biomed Sci (2000) 2.21

Effect of bright light and melatonin on cognitive and noncognitive function in elderly residents of group care facilities: a randomized controlled trial. JAMA (2008) 2.07

The Mental Activity and eXercise (MAX) trial: a randomized controlled trial to enhance cognitive function in older adults. JAMA Intern Med (2013) 2.05

Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev (2003) 2.05

Apolipoprotein E alleles as risk factors in Alzheimer's disease. Annu Rev Med (1996) 2.04

Exercise and sleep. Sleep Med Rev (2000) 2.04

Sleep and circadian rhythms: key components in the regulation of energy metabolism. FEBS Lett (2007) 2.03

Dose-response relationship for light intensity and ocular and electroencephalographic correlates of human alertness. Behav Brain Res (2000) 2.01

Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 2.01

Mild cognitive impairment: disparity of incidence and prevalence estimates. Alzheimers Dement (2012) 2.00

Effects of exercise on sleep. Clin Sports Med (2005) 1.96

Risk of napping: excessive daytime sleepiness and mortality in an older community population. J Am Geriatr Soc (1996) 1.96

What sleep characteristics predict cognitive decline in the elderly? Sleep Med (2012) 1.96

Review: cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol Appl Neurobiol (2011) 1.91

The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res (1985) 1.87

Sleep in spousal caregivers of people with Alzheimer's disease. Sleep (2005) 1.83

Alzheimer's disease. Cold Spring Harb Perspect Biol (2011) 1.81

Sleep and Alzheimer disease pathology--a bidirectional relationship. Nat Rev Neurol (2013) 1.78

Social influences on mammalian circadian rhythms: animal and human studies. Biol Rev Camb Philos Soc (2004) 1.77

Alterations in the circadian rest-activity rhythm in aging and Alzheimer's disease. Biol Psychiatry (1990) 1.74

Living by the clock: the circadian pacemaker in older people. Ageing Res Rev (2005) 1.73

Individual differences in the amount and timing of salivary melatonin secretion. PLoS One (2008) 1.72

Mild cognitive impairment: a concept in evolution. J Intern Med (2014) 1.65

Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev (2011) 1.65

Deciphering the mechanism underlying late-onset Alzheimer disease. Nat Rev Neurol (2012) 1.64

Disrupted daily activity/rest cycles in relation to daily cortisol rhythms of home-dwelling patients with early Alzheimer's dementia. Brain (2004) 1.63

Bright light effects on body temperature, alertness, EEG and behavior. Physiol Behav (1991) 1.62

Sleep problems and institutionalization of the elderly. J Geriatr Psychiatry Neurol (1992) 1.62

Circadian regulation of sleep in mammals: role of the suprachiasmatic nucleus. Brain Res Brain Res Rev (2005) 1.61

Resistance training and functional plasticity of the aging brain: a 12-month randomized controlled trial. Neurobiol Aging (2011) 1.59

APOE distribution in world populations with new data from India and the UK. Ann Hum Biol (2006) 1.59

Does lack of sleep cause diabetes? Cleve Clin J Med (2011) 1.54

Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry (1996) 1.54

Effect of light treatment on sleep and circadian rhythms in demented nursing home patients. J Am Geriatr Soc (2002) 1.53

Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? J Neurol Sci (2007) 1.52

Locomotor activity and non-photic influences on circadian clocks. Biol Rev Camb Philos Soc (1996) 1.52

Combinations of bright light, scheduled dark, sunglasses, and melatonin to facilitate circadian entrainment to night shift work. J Biol Rhythms (2003) 1.51